Maharashtra News: According to a state health department study released on Tuesday, the samples received for genome sequencing of COVID-19 positive individuals in Maharashtra 80% of them were tested positive for the Delta variant.
Maharashtra is regularly conducting genome sequencing tests on COVID-19 positive patients’ samples to determine the extent of the virus’s mutations’ transmission.
Each centre sends 15 samples to the National Institute of Virology in Pune every two weeks for genome sequencing.
A contract has also been inked with the Institute of Genomics and Integrative Biology, which is part of the Council of Scientific and Industrial Research (CSIR).
This laboratory tests 100 samples of each district of Maharashtra to find if there is any mutant virus present in any of the samples.
On Monday, Institute of Genomics and Integrative Biology found 10 more people positive with Delta Plus variant.
Six of them are from the Kolhapur district, three from Ratnagiri, and one from Sindhudurg. So far, 13 Delta Plus cases have been reported in Jalgaon, 15 in Ratnagiri, 11 in Mumbai, seven in Kolhapur, six in Pune and Thane, three each in Palghar and Raigad, two in Gondia, Sindhudurg, and Nanded, and one each in Chandrapur, Akola, Sangli, Nandurbar, Aurangabad, and Beed.
To detect Delta Plus patients, the state government has developed fast reaction teams. They look into the patients’ travel history as well as vaccination records. They also conduct a survey to see if people are experiencing flu-like symptoms.
There have been 39 Delta Plus cases documented in people aged 19-45 years, 19 in people aged 46-60 years, nine patients under the age of 18 years, and nine people beyond the age of 60 years.
According to the news agency PTI, 39 of the 76 Delta Plus cases were female and 37 were male.
Meanwhile, the state health agency said that of the 76 people, 10 had received both doses of the COVID-19 vaccination, while 12 had received only the first dosage, resulting in 22 people receiving at least one dose of the vaccine.
Covaxin was given to two of the 22 participants, while Covishield was given to the other 20. The symptoms of 37 Delta Plus-infected patients ranged from mild to none at all.
According to the health warning, the Delta Plus variety caused one death each in Mumbai, Beed, and Raigad, and two deaths in Ratnagiri.
The symptoms of 37 Delta Plus-infected patients ranged from mild to none. According to the health warning, the Delta Plus variety caused one death each in Mumbai, Beed, and Raigad, and two deaths in Ratnagiri. All of the individuals who died as a result of the modified virus were over 65 years old and had major co-morbidities. Two of the five had received both doses of Covishield, whereas the other three had not been vaccinated against COVID-19 at all.